北大医药(000788.SZ)：奥氮平片获得《药品补充申请批准通知书》

Core Viewpoint - North China Pharmaceutical (000788.SZ) has received approval from the National Medical Products Administration for the supplementary application of Olanzapine tablets, an antipsychotic medication used for treating schizophrenia and bipolar disorder [1] Group 1: Product Information - Olanzapine is indicated for the treatment of schizophrenia, providing effective initial treatment for patients [1] - It is also used for the treatment of moderate to severe manic episodes, and can prevent the recurrence of bipolar disorder in patients who respond well to the treatment [1]